Dr. Abribat talks Amolyt Pharma: Advance therapeutic peptides treat endocrine and metabolic diseases
We sit down and talk to Dr. Abribat about Amolyt Pharma, which is developing therapeutic peptides to treat rare endocrine and metabolic diseases. The company recently announced that it has dosed the first patient in a Phase 1 clinical trial evaluating its experimental therapeutic peptide, AZP-3601, for a life-altering rare disease called hypoparathyroidism. This is Amolyt’s first clinical trial as a company. The trial, being conducted at sites in Europe, will test whether AZP-3601 will benefit patients with hypoparathyroidism by restoring lasting levels of calcium in their blood. Thierry Abribat, PhD can discuss why therapeutic peptides may provide better treatment options for patients with rare endocrine and metabolic diseases, the unmet need in hypoparathyroidism, AZP-360 and the ongoing trial.
You can check out Amolyt Pharma Here:
https://amolytpharma.com/
-
27:09
Dr. Eric Berg
5 months agoWho Is Dr. Berg's Doctor? Metabolomics Discussion
2.46K2 -
50:35
Myers Detox
4 months agoPeptides for Anti-aging and Weight Loss With Dr. Clement Lee
853 -
2:32
Supplements, Sports Nutrition and Fitness
1 year agoHi-Tech Pharmaceuticals 1-AD 1-Andro ProHormone Overview
4 -
0:51
STLNutritionDoc
1 year agoPharmacology & pharmaceuticals
19 -
51:38
FGP
7 months agoTherapeutic Strategies For Managing Cancer | Is Cancer A Metabolic Disorder? An Expert Explains
69 -
1:09:30
Chris Beat Cancer
9 months agoDr. Baxter Montgomery prescribes plants to reverse heart disease, obesity and diabetes
272 -
1:31:46
DocFarhan
1 year agoANDROGEN TALK Pt. 2 - How Peptides Are Changing The Health And Fitness Industry
24 -
2:33
BrioMedical
6 months agoPersonalized Peptides for the Treatment of Cancer | Brio-Medical Cancer Clinic in Scottsdale, AZ
31 -
1:05:28
Free Your Mind Videos
7 months agoCancer Breakthrough: How Metabolic Therapy is Changing Lives
2.12K1 -
10:58
TheRealTruthAboutHealth
1 year agoA Novel Therapeutic Strategy For The Metabolic Management Of Cancer
291